Early-onset Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation

被引:11
作者
Bitan, M
Or, R
Shapira, MY
Mador, N
Resnick, IB
Saleh, N
Weinberger, KM
Samuel, S
Schechter, E
Slavin, S
Wolf, DG
机构
[1] Hadassah Univ Hosp, Dept Bon Marrow Transplantat & Canc Immunotherapy, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel
[3] Univ Regensburg, Inst Med Microbiol & Hyg, D-8400 Regensburg, Germany
关键词
D O I
10.1086/424015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report a case of early-onset acute Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus (EBV) infection after nonmyeloablative stem cell transplantation (NST). Reactivation of EBV infection preceded disease onset, and the virus load increased concomitantly with disease progression ( doubling time, 2.7 days). This case raises concern about the expanding scope of manifestations associated with reactivation of EBV infection after NST.
引用
收藏
页码:1076 / 1078
页数:3
相关论文
共 12 条
[1]   Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy [J].
Darenkov, IA ;
Marcarelli, MA ;
Basadonna, GP ;
Friedman, AL ;
Lorber, KM ;
Howe, JG ;
Crouch, J ;
Crouch, J ;
Bia, MJ ;
Kliger, AS ;
Lorber, MI .
TRANSPLANTATION, 1997, 64 (06) :848-852
[2]   Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts [J].
Emery, VC ;
Hassan-Walker, AF ;
Burroughs, AK ;
Griffiths, PD .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (12) :1723-1728
[3]   B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome [J].
Gross, TG ;
Steinbuch, M ;
DeFor, T ;
Shapiro, RS ;
McGlave, P ;
Ramsay, NKC ;
Wagner, JE ;
Filipovich, AH .
BONE MARROW TRANSPLANTATION, 1999, 23 (03) :251-258
[4]   Successful treatment of Epstein-Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantation [J].
Gruhn, B ;
Meerbach, A ;
Egerer, R ;
Mentzel, HJ ;
Häfer, R ;
Ringelmann, F ;
Sauer, M ;
Hermann, J ;
Zintl, F .
BONE MARROW TRANSPLANTATION, 1999, 24 (12) :1355-1358
[5]   Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease [J].
Humar, A ;
Kumar, D ;
Boivin, G ;
Caliendo, AM .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (06) :829-833
[6]   Rapid occurrence of lymphoproliferative disease after pancreas-kidney transplantation performed during acute primary Epstein-Barr virus infection [J].
Kroes, ACM ;
vanderPijl, JW ;
vanTol, MJD ;
vanKrieken, JHJM ;
Falk, KI ;
Gratama, JW ;
vanderWoude, FJ .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) :339-343
[7]   Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen [J].
Morecki, S ;
Gelfand, Y ;
Nagler, A ;
Or, R ;
Naparstek, E ;
Varadi, G ;
Engelhard, D ;
Akerstein, A ;
Slavin, S .
BONE MARROW TRANSPLANTATION, 2001, 28 (03) :243-249
[8]  
SHAPIRO RS, 1988, BLOOD, V71, P1234
[9]   Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases [J].
Slavin, S ;
Nagler, A ;
Naparstek, E ;
Kapelushnik, Y ;
Aker, M ;
Cividalli, G ;
Varadi, G ;
Kirschbaum, M ;
Ackerstein, A ;
Samuel, S ;
Amar, A ;
Brautbar, C ;
Ben-Tal, O ;
Eldor, A ;
Or, R .
BLOOD, 1998, 91 (03) :756-763
[10]   Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT [J].
van Esser, JWJ ;
van der Holt, B ;
Meijer, E ;
Niesters, HGM ;
Trenschel, R ;
Thijsen, SFT ;
van Loon, AM ;
Frassoni, F ;
Bacigalupo, A ;
Schaefer, UW ;
Osterhaus, ADME ;
Gratama, JW ;
Löwenberg, B ;
Verdonck, LF ;
Cornelissen, JJ .
BLOOD, 2001, 98 (04) :972-978